Table 1.
Clinical characteristics and hormones level in the two sub-groups of participants based on Anti-Mullerian hormone (AMH) levels.
| Age ≤ 35 years | Age > 35 years | ||||||
|---|---|---|---|---|---|---|---|
| AMH < 1.1 ng/ml Median (IQR) |
AMH ≥ 1.1 ng/ml Median (IQR) |
P-value | AMH < 1.1 ng/ml Median (IQR) |
AMH ≥ 1.1 ng/ml Median (IQR) |
*P-value | ||
| BMI | 26.6 (24.96–29.2) | 27.0 (24.50–29.77) | 0.909 | 27.6 (25.5–30.4) | 28.4 (26.68–31.32) | 0.102 | |
| Clinical hypothyroidism | yes | 2 (66.7%) | 1 (33.3%) | 0.096 | 6 (100%) | 0 | 0.181 |
| no | 22 (18.2%) | 99 (81.8%) | 127 (69%) | 57 (31%) | |||
| total | 24 (19.4%) | 100 (80.6%) | 133 (70%) | 57 (30%) | |||
| Subclinical hypothyroidism | yes | 2 (28.6%) | 5 (71.4%) | 0.525 | 15 (83.3%) | 3 (16.7%) | 0.194 |
| no | 22 (18.8%) | 95 (81.2%) | 118 (68.6%) | 54 (31.4%) | |||
| total | 24 (19.4%) | 100 (80.6%) | 133 (70%) | 57 (30%) | |||
| TSH (mIU/L) | 1.97 (1.22–3.69) | 2.1 (1.46–3.2) | 0.09 | 2.3 (1.3–3.5) | 1.8 (1.8–3.25) | 0.03 | |
| Free T4 (ng/dl) | 8.55 (6.75–11.42) | 8.77 (7.51–10.15) | 0.98 | 8.5 (6.5–9.8) | 8.83 (7.8–10.1) | 0.05 | |
| FSH (IU/L) | 9.95 (7.92–17.55) | 5.5 (4.1–6.8) | 0.0001 | 8.7 (5.85–11.85) | 6.5 (4.75–7.8) | 0.0001 | |
| E2 (pg/ml) | 39.5 (26.67–70.45) | 48 (37.2–68.15) | 0.12 | 57.1 (33–81.15) | 49 (35.6–68.7) | 0.29 | |
*Mann–Whitney U test
AMH Anti-Mullerian hormone, IQR Interquartile range, FSH Follicle-stimulating hormone, E2 Estradiol, TSH Thyroid stimulating hormone, Free T4 Thyroxine